MANUAL has acquired FORMEL SKIN for an undisclosed amount, marking a significant strategic move in the digital health sector. FORMEL SKIN is a HealthTech startup with a mission to offer individualized, high-quality medical treatments online, directly addressing multiple challenges faced by dermatologists and patients today. The company, backed by prominent early-stage VCs Cherry Ventures and Heartcore Capital, has successfully facilitated over one million treatments.
FORMEL SKIN's operational model involves patients registering online, completing a detailed questionnaire, and uploading photos of their specific concerns, such as acne, rosacea, or fine lines. A personal doctor is then assigned to decide on the required medical treatment, adjusting it monthly based on patient feedback and results. These personalized treatments are created by pharmacies and subsequently shipped directly to the patient each month. MANUAL, a leading digital health platform, specializes in delivering personalized medical solutions across various health areas.
This acquisition is designed to generate substantial synergies by integrating FORMEL SKIN's proven expertise in online dermatological care with MANUAL's broader digital health infrastructure. The move strategically expands MANUAL's service offerings into a specialized and rapidly growing segment of personalized healthcare, leveraging FORMEL SKIN's established patient base and efficient operational model. For FORMEL SKIN, joining MANUAL provides access to enhanced resources and scale, furthering its mission to make expert dermatological care more accessible and effective.
The strategic takeover highlights the increasing demand for accessible, tailored medical solutions delivered through digital channels. The combined entity is poised to enhance the patient experience by broadening the scope of conditions treated and streamlining the delivery of personalized health interventions, aiming to solidify its position within the competitive HealthTech landscape.